All trials at Texas Heart Institute must protect patient safety first and foremost.
Our investigators carefully follow protocols designed to maximize benefits and reduce risks.
Our trials are reviewed and monitored by independent Institutional Review Boards (IRBs) and, if required, the Food and Drug Administration (FDA) to ensure patient safety and regulatory compliance.
Our clinical trials have strict eligibility requirements that investigators must follow when enrolling study participants.
Texas Heart Institute provides eligible patients with an informed consent process. During this process, patients can ask questions and receive study information before deciding to participate in a clinical trial.
A patient’s participation in a clinical trial is always voluntary and the patient can stop participation any time.